The 30-second summary
- GLP-1s work just as well after menopause. A 2026 analysis of the SURMOUNT program found tirzepatide delivered similar weight loss across all reproductive stages.
- Menopause already speeds muscle and bone loss as oestrogen falls. A GLP-1's rapid loss on top is a second subtraction, so protection matters more, not less.
- The tools are unglamorous and proven: enough protein, resistance training, and a conversation about hormone therapy with your prescriber.
The good news first
Many women reach for a GLP-1 precisely because menopause changed everything: the weight settled around the middle, the old routines stopped working, and the scale would not move. It was a fair worry whether the drug would even work against that hormonal headwind.
It does. A 2026 analysis splitting the large SURMOUNT tirzepatide trial by reproductive stage found weight loss of roughly 20 percent whether women were premenopausal, perimenopausal, or postmenopausal. The medication does not weaken in midlife.
The asterisk that matters
What changes in menopause is not the drug's power, it is the stakes around muscle and bone.
From the early forties, falling oestrogen speeds the natural loss of muscle and thins bone by around one percent a year on its own. Layer a GLP-1's fast weight loss on top and you have two forces pulling the same direction. This is why the muscle and bone question, which matters for every woman on a GLP-1, matters most here. (See GLP-1s in perimenopause and bone density on a GLP-1.)
The three levers
- Protein. A floor of 1.2 to 1.6 grams per kilogram of goal weight, about 120 grams a day, gives muscle the raw material to hold on. (See protein on a GLP-1.)
- Resistance training. Two short sessions a week loads muscle and bone at once, the single best insurance against losing the wrong kind of weight. (See strength training that fits a tired body.)
- Hormone therapy, considered. HRT treats menopause symptoms in their own right and, in early research, may modestly add to GLP-1 weight loss. It is your prescriber's call, made with your history.
What Steady does with this
Steady was built for exactly this woman: on a GLP-1, in the middle of a hormonal shift no one prepared her for.
- A protein target to protect the muscle and bone menopause is already working against.
- Strength sessions tracked in a weekly scorecard, so the habit that protects both becomes a number you can see.
- Your symptoms and cycle stage read together, so a hard week reads as biology, not failure.
The drug works in menopause. Steady helps make sure the weight you lose is the right kind.
Read next: GLP-1s in perimenopause, why muscle is the number that matters, and bone density on a GLP-1.
Sources
- Post-hoc analysis of tirzepatide by reproductive stage, SURMOUNT program. 2026. PMC
- Volpi E, et al. Muscle tissue changes with aging (sarcopenia). Curr Opin Clin Nutr Metab Care 2004. PubMed
- NAMS. The role of hormone therapy in midlife women. Menopause.org
Medical disclaimer: Articles in the Steady research hub are educational, not medical advice. Menopause, hormone therapy, and medication decisions belong with your doctor. See our full medical disclaimer.